Newer blood cancer drugs may not improve OS, QOLOctober 6, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLHodgkin LymphomaCMLNon-Hodgkin Lymphoma
How Abl ‘shape-shifts’ in drug-resistant CMLOctober 4, 2017Leukemia, Myelodysplasia, TransplantationCML
CHMP recommends approval of generic imatinibSeptember 18, 2017CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationPharmacyALLMyelodysplastic SyndromeCML
CHMP recommends approval of nilotinib for kidsSeptember 16, 2017Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyCML
Report details progress, obstacles in cancer research and careSeptember 14, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPediatricsRelated IssuesAMLALL
TKI granted priority review for newly diagnosed CMLAugust 30, 2017Leukemia, Myelodysplasia, TransplantationPharmacyCML
Popular theory of mast cell development is wrong, team saysAugust 15, 2017Leukemia, Myelodysplasia, TransplantationCML
De-escalation may improve success of TKI cessationJuly 14, 2017Leukemia, Myelodysplasia, TransplantationCML
FDA grants priority review to sNDA for dasatinibJuly 12, 2017Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyCML
EU label for nilotinib now includes info on stopping therapyJune 9, 2017Leukemia, Myelodysplasia, TransplantationCML
Dasatinib potentially a new SOC for children with CML-CPJune 9, 2017Leukemia, Myelodysplasia, TransplantationPediatricsCML
Authority on hematologic malignancies diesMay 31, 2017AnemiaLeukemia, Myelodysplasia, TransplantationMyelodysplastic SyndromeCML
Single-cell analysis reveals TKI-resistant CML stem cellsMay 18, 2017Leukemia, Myelodysplasia, TransplantationCML
